About Susan Orr
Susan Orr is a chief medical officer at Claris Biotherapeutics.
Susan Orr first appears on SEC filings in 2024.
Experience
This experience comes from Susan Orr's profile and from SEC filings. For roles taken from filings, the years are when the filings name Susan Orr in the role, so the role may have started earlier or lasted longer.
Claris Biotherapeutics, Inc. Current
Chief Medical Officer
2020 – Present · Half Moon Bay, CA
Develops eye treatments for people with sight-threatening corneal diseases.
FC
Fovendeye Consulting Current
Managing Partner
2016 – Present
RG
RETINA GLOBAL Current
Board Member
2015 – Present
OP
Opthea
Board Member
2022 – 2025
NV
Notal Vision
Chief Executive Officer and Board Member
2016 – 2019
JJ
Janssen, Pharmaceutical Companies of Johnson and Johnson
Global Medical Affairs Leader & Strategy, Search & Evaluation, Ophthalmology
2014 – 2016
AC
Alcon, a Novartis company
Global Head, New Product & Product Strategy (2010 – 2014)
Director, Retina, R&D Alliances (2009 – 2010)
2009 – 2014
AI
Alcon Laboratories, Inc.
Associate Director, Retina and Consumer Products, BD&L
2000 – 2009
AL
Alcon Research, Ltd.
Assistant Director, Clinical Pharmacology
2004 – 2007
Key Colleagues at Startups
The people Susan Orr works with at each company, as listed on that company's latest Form D.
Claris Biotherapeutics, Inc. · Form D/A, Aug 12, 2026
Brian Baum
Chief Commercial Officer
MF
Meredith Fisher
Director
RD
Reza Dana
Director
Stephen Brady
President and Chief Executive Officer, director
Henry Rath
Chief Business Officer
KH
Kenneth Harrison
Director
MH
Matt Hobson
Director
MD
Michael Dybbs
Director
MR
Maha Radhakrishnan
Director
Clarke Atwell
Co-Founder and Chief Operating Officer
MG
Marc de Garidel
Director